Physician

Michael A Mecley, MD

According to 2025 Medicare claims, Michael Mecley, MD (NPI: 1609828920) practices cardiology in the Barnstable Town, MA market, with the plurality of this provider's patient population coming from Barnstable, MA. This provider's primary affiliated billing organization is CARDIOVASCULAR CONSULTANTS OF CAPE COD LLC (NPI: 1316998313; TIN: 562536101) and primary practice location at 02601-3064.

Mecley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,292 traditional Medicare patients, billed 7,411 HCPCS/CPT codes, and received $521,513 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,990 prescription claims across 918 beneficiaries totaling $2,103,696 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 24 claims. Open Payments data shows 101 records totaling $2,193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $481,626 to $2,103,696. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,830 and ending at $1,334.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,579	7,802	$412,084
2016	1,556	6,551	$420,950
2017	1,231	6,259	$435,836
2018	1,179	7,078	$426,657
2019	1,224	7,538	$429,552
2020	1,105	6,828	$367,700
2021	1,261	7,565	$502,068
2022	1,415	8,011	$525,639
2023	1,303	7,458	$487,684
2024	1,292	7,411	$521,513

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	490	4,514	$481,626
2016	532	4,797	$517,607
2017	538	4,689	$606,915
2018	568	4,820	$740,809
2019	643	5,082	$960,504
2020	693	5,558	$1,114,398
2021	768	5,726	$1,338,151
2022	844	6,487	$1,792,537
2023	851	6,771	$2,101,588
2024	918	6,990	$2,103,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,346
2016	N/R	11	$965
2017	N/R	N/R	N/R
2018	N/R	21	$1,146
2019	N/R	14	$797
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$1,308
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	424	440	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,060	1,973	$97
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	298	314	$54
93356	Heart muscle strain imaging	320	328	$31
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,123	2,118	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	715	52,693	$985,446
Xarelto	Rivaroxaban	189	15,060	$268,783
Entresto	Sacubitril/Valsartan	140	10,306	$221,161
Jardiance	Empagliflozin	189	11,287	$204,922
Farxiga	Dapagliflozin Propanediol	98	6,877	$126,998

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$2,193	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael A. Mecley, MD?

Tedicare shows public-source Medicare data for Michael A. Mecley, MD (NPI 1609828920), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael A. Mecley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael A. Mecley, MD?

Michael A. Mecley, MD is linked to CARDIOVASCULAR CONSULTANTS OF CAPE COD LLC (billing NPI 1316998313) in the available physician profile data.

Does Michael A. Mecley, MD have Open Payments data?

Michael A. Mecley, MD has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.